Author Correction: The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer

被引：0
|
作者：
Ilenia Masi [1 ]
Flavia Ottavi [1 ]
Danila Del Rio [1 ]
Valentina Caprara [2 ]
Cristina Vastarelli [1 ]
Sara Maria Giannitelli [3 ]
Giulia Fianco [1 ]
Pamela Mozetic [4 ]
Marianna Buttarelli [5 ]
Gabriella Ferrandina [6 ]
Giovanni Scambia [7 ]
Daniela Gallo [6 ]
Alberto Rainer [7 ]
Anna Bagnato [6 ]
Francesca Spadaro [7 ]
Laura Rosanò [6 ]
机构：
[1] Institute of Molecular Biology and Pathology,Unit of Preclinical Models and New Therapeutic Agents
[2] CNR,Department of Engineering
[3] IRCCS—Regina Elena National Cancer Institute,Institute of Nanotechnology (NANOTEC)
[4] Università Campus Bio-Medico di Roma,San Raffaele Hospital, Division of Neuroscience
[5] National Research Council (CNR),undefined
[6] c/o Campus Ecotekne,undefined
[7] Institute of Experimental Neurology,undefined
[8] San Raffaele Scientific Institute,undefined
[9] Dipartimento Universitario Scienze della Vita e Sanità Pubblica-Sezione di Ginecologia ed Ostetricia—Università Cattolica del Sacro Cuore,undefined
[10] Dipartimento Scienze della Salute della Donna,undefined
[11] del Bambino e di Sanità Pubblica,undefined
[12] Fondazione Policlinico Universitario A. Gemelli,undefined
[13] IRCCS,undefined
[14] Largo A. Gemelli 8,undefined
[15] Confocal Microscopy Unit,undefined
[16] Core Facilities,undefined
[17] Istituto Superiore di Sanità,undefined
来源：
Cell Death & Disease | / 15卷 / 10期
关键词：
D O I：
10.1038/s41419-024-07139-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PD-L1 Expression in High-Grade Serous and Clear Cell Ovarian Cancer
    Ljubiša Jovanović
    Andja Ćirković
    Milena Jović
    Radmila Janković
    Indian Journal of Gynecologic Oncology, 2022, 20
  • [22] IDH1 IS A PRO-SENESCENT THERAPY IN HIGH-GRADE SEROUS OVARIAN CANCER
    Dahl, Erika S.
    Snyder, Nathaniel W.
    Aird, Katherine M.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 86 - 86
  • [23] PD-L1 Expression in High-Grade Serous and Clear Cell Ovarian Cancer
    Jovanovic, Ljubisa
    Cirkovic, Andja
    Jovic, Milena
    Jankovic, Radmila
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (04)
  • [24] BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer
    Huang, Jiazhen
    Tang, Ying
    Li, Yibing
    Wei, Wei
    Kang, Fuli
    Tan, Shuang
    Lin, Lin
    Lu, Xiaohang
    Wei, Heng
    Wang, Ning
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2024, 1871 (08):
  • [25] Endothelin-1 receptor/beta-arrestin-1 pathway promotes invadopodia and metastatic process by integration with hMENA in human serous ovarian cancer
    Caprara, Valentina
    Di Modugno, Francesca
    Chellini, Lidia
    Tocci, Piera
    Spadaro, Francesca
    Sacconi, Andrea
    Blandino, Giovanni
    Nistico, Paola
    Bagnato, Anna
    Rosano, Laura
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Ryanodine receptor-1 contributes toenhanced cytoplasmic andnucleoplasmic calcium signaling in high-grade serous ovarian cancer (HGSOC)
    Yip, Kay-Pong D.
    Au-Yeung, Chi-Lam
    Tang, Wan-Yee
    Mok, Samuel C.
    Sham, James S. K.
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 517A - 517A
  • [27] Upregulation of ryanodine receptor-1 dependent calcium signaling contributes to the malignance of high-grade serous ovarian cancer (HGSOC)
    Yip, Kay-Pong D.
    Au-Yeung, Chi-Lam
    Zhang, Li
    Mok, Samuel C.
    Sham, James S. K.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 163A - 163A
  • [28] Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
    Tocci, Piera
    Roman, Celia
    Sestito, Rosanna
    Di Castro, Valeriana
    Sacconi, Andrea
    Molineris, Ivan
    Paolini, Francesca
    Carosi, Mariantonia
    Tonon, Giovanni
    Blandino, Giovanni
    Bagnato, Anna
    CELL DEATH & DISEASE, 2023, 14 (01)
  • [29] Constitutional BRCA1 methylation is a major predisposition factor for high-grade serous ovarian cancer
    Dobrovic, Alexander
    Mikeska, Thomas
    Alsop, Kathryn
    Candiloro, Ida
    George, Joshy
    Mitchell, Gillian
    Bowtell, David
    CANCER RESEARCH, 2014, 74 (19)
  • [30] ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification
    Huang, Jiazhen
    Tang, Ying
    Li, Yibing
    Wei, Wei
    Kang, Fuli
    Tan, Shuang
    Lin, Lin
    Lu, Xiaohang
    Wei, Heng
    Wang, Ning
    CELLULAR SIGNALLING, 2024, 116
12345